Linearity [Regulatives / Guidelines]

posted by jag009  – NJ, 2022-01-24 16:06 (959 d 15:37 ago) – Posting: # 22752
Views: 2,992

Hi Ohlbe,

❝ Does your drug show linear PK ? If not: does it show more-than-proportional increase (then the highest strength would be more sensitive to show differences in BA) or less-than-proportional increase (lowest strength would be more sensitive, giving you good arguments) ?


Yes its linear PK. I read the FDA guidance about Guidance, for NDA it seeems "possible" as long as one can provide safety and efficacy data.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,221 posts in 4,877 threads, 1,656 registered users;
51 visitors (1 registered, 50 guests [including 9 identified bots]).
Forum time: 08:44 CEST (Europe/Vienna)

Explanations exist; they have existed for all time;
there is always an easy solution to every human problem –
neat, plausible and wrong.    H. L. Mencken

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5